Figure 1.
Kaplan–Meier analysis of OS and TTP in NSCLC patients according to the cfDNA increase.
cfDNA, circulating free DNA; NSCLC, non-small cell lung cancer; OS, overall survival; TTP, time to progression.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.